Mangalam Drugs and Organics Limited announced the outcome of its Board Meeting held on January 15, 2026. The Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended January 15, 2026, along with the Limited Review Report.

The Board also accepted the resignation of Mr. Ajay Samant from the position of Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). His resignation, tendered on November 5, 2025, is effective from January 31, 2026, citing health reasons. The Board also took note of the resignation of Ms. Anuradha Pandey, Company Secretary & Compliance Officer, submitted on January 2, 2026.

The company declared that the statutory auditors have not expressed any modified opinions in their audit reports concerning the financial results. The Board meeting commenced at 12:00 PM and concluded at 2:30 PM.